B

Baroness Nargund (Lab)

Speaking in the House of Lords on 15 June 2026

Debate

Rare Cancers: Diagnosis and Treatment

Contribution

My Lords, I thank the noble Baroness, Lady Finlay, for this very important Question and for raising the hub and spoke model for cancer trials. Rare cancer trials involve fewer patients and less data, which makes it very difficult to conduct the large, randomised studies that are needed for NICE approval and to produce evidence for innovative treatments. Are the Government considering asking NICE to review or revise its assessment methods so that innovative treatments can be approved with fewer patients and less data because of the difficulties in doing large trials, so that patients are not left behind?

More from Baroness Nargund (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites